Navigation Links
BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
Date:10/28/2008

A Single Dose of Peramivir is Effective and Well-Tolerated at Both 300 mg and 600 mg Dose Levels

BIRMINGHAM, Ala., Oct. 28 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that a double-blind, placebo-controlled, Phase 2 study of intravenous (i.v.) peramivir, administered via a single dose injection in outpatients with acute, uncomplicated influenza, met its primary endpoint of time to alleviation of symptoms for both the 300 mg dose (p=0.0046) and 600 mg dose (p=0.0046). The study was sponsored by BioCryst's partner for peramivir, Shionogi & Co., Ltd.

The poster titled, "A Double-Blind, Placebo-Controlled Study of Intravenous Peramivir in Acute Influenza Patients" (Poster Session # 302: Respiratory Viruses I: Influenza and RSV) will be presented on Tuesday, October 28 from 12:15 p.m. - 1:15 p.m. Eastern Time in Hall C by Dr. Shigeru Kohno, Dean, Nagasaki University Graduate School of Medicine and Professor, Infection Immunology Department, Nagasaki University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.

"This Phase 2 study was a critical test of peramivir, which demonstrated for the first time that a single administration of this potent neuraminidase inhibitor can be effective in treating seasonal influenza," said Dr. William P. Sheridan, Chief Medical Officer of BioCryst. "The promising data in outpatient influenza highlights the potential of the compound as a novel and effective influenza therapy and we look forward to learning more about the clinical advantages of peramivir in the upcoming Shionogi-sponsored Phase 3 program."

The randomized, double-blind, placebo-controlled, Phase 2 study conducted in Japan enrolled 300 patients age 20 to 64, who
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. BioCryst Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 8, 2008
2. BioCryst to Release Third Quarter 2007 Financial Results on Thursday, November 8, 2007
3. Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008
4. LCA-Vision Reports Third Quarter 2008 Financial Results
5. Universal Health Services, Inc. Reports 2008 Third Quarter Results
6. PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results
7. Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009
8. WellPoint Reports Third Quarter 2008 Results
9. Forest Laboratories, Inc. Reports Fiscal Second Quarter 2009 Earnings per Share of $0.80
10. Schering-Plough Reports Financial Results for Third Quarter of 2008
11. Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... latest blog post, Best Drug Rehabilitation , which offers ... a stay in rehab can make a big difference in ... 10 tips to help drug or alcohol addicts cope after ... and one that former addicts and those who support them ... Rehabilitation’s CEO Per Wickstrom . , According to ...
(Date:7/31/2014)... Thanks to its mildly sweet flavor ... been used as a medium for delivery of ... However consistent, dependable sourcing of erythritol often fluctuates. ... and beverage manufacturers’ increasing needs for reliable, dependable, ... ErysweetTM Erythritol. , “Erysweet is unique in ...
(Date:7/31/2014)... 2014 Nuanced Media, a leading digital ... the Nuanced Medical website . Nuanced Medical, and ... of the Medical Industry. , The idea behind Nuanced ... medical practices to meet continuously changing federal regulations. The ... Act (Health Insurance Portability and Accountability Act), which is ...
(Date:7/30/2014)... Calling all runners in the Richmond, VA region. , ... a monthly Runner’s Injury Clinic at the Glen ... second Monday of each month through the end of the ... and December 8. , The clinics run from 5:30 ... shoes and attire, will receive a complimentary evaluation of running ...
(Date:7/30/2014)... July 31, 2014 Responding to ... environment more responsive to an increasingly diverse patient ... experience and scholarly expertise to the publication of ... care professions: "Diversity and Cultural Competence in Health ... L. Dreachslin, PhD, a professor in the Management ...
Breaking Medicine News(10 mins):Health News:New Best Drug Rehabilitation Blog Posts Looks at 10 Tips for Coping After Drug or Alcohol Rehab 2Health News:Steviva Ingredients Launches Erysweet Erythritol 2Health News:Nuanced Media, HIPAA Certified Agency, Launches Medical Web Design Service Website 2Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 2Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 3Health News:NLN CEO Co-Authors Textbook to Advance Diversity and Cultural Competence Across Health Care Professions 2Health News:NLN CEO Co-Authors Textbook to Advance Diversity and Cultural Competence Across Health Care Professions 3
... today that it has reached an agreement to sell ... asset-backed commercial paper (ABCP) with,a book value of $7.0 ... right to receive additional proceeds in the event the,buyer ... event, Westaim,will receive 50 per cent of any proceeds ...
... 26 ALLDATA SHREDDING INC., the leading,Pacific Northwest information ... tomorrow. The closely-held,family-owned and operated company commemorates the following ... zero security breaches. -- An overall performance rating ... & Bradstreet,s Open Ratings. ...
... SINGAPORE, Nov. 26 Flextronics (Nasdaq: FLEX ),today ... Tuesday,January 29, 2008., The earnings conference call, hosted ... PST to discuss the financial results,of the Company for ... earnings call will be available via the Internet and ...
... Computed tomography (CT) angiography is as accurate as an ... the findings of the first two prospective multicenter 64-slice ... the Radiological Society of North America (RSNA). , ... stage for the widespread adoption of and reimbursement for ...
... It may be undertreated compared to white patients, research suggests ... more likely than white women to suffer severe pain linked ... more than 1,100 patients in 19 countries. , The women ... were given a pain test called the Brief Pain Inventory ...
... Mich., Nov. 26 In keeping with its,commitment to ... Care Network of Michigan, a leading HMO in the ... among its own employees at the,workplace., BCN, which ... of,Michigan, earlier this year instituted Wellness Works!, an employee ...
Cached Medicine News:Health News:Westaim reduces ABCP exposure 2Health News:ALLDATA SHREDDING Celebrates Fifth Anniversary With 'A' Grade From Clients 2Health News:Flextronics to Report Third Quarter Results 2Health News:CT angiography highly accurate, multicenter trials show 2Health News:Leading by Example: Blue Care Network of Michigan Shows How Employers Can Improve Employee Wellness 2
(Date:7/30/2014)... July 30, 2014 In conjunction with DURECT ... financial results press release, you are invited to listen ... over the internet on Thursday, August 7, 2014 at ... A live audio webcast of the presentation will ... and clicking "Investor Relations."  If you are unable ...
(Date:7/30/2014)... 2014 The Board of Directors of ... evening expressed support for the "Pharmacists, Patient Care ... Pharmacy Practitioners (JCPP).  As a JCPP member, AMCP ... period to develop a scalable, viable and consistent ... "Pharmacists are fast becoming one of the most ...
(Date:7/30/2014)... , July 30, 2014 Research and Markets ... Market - Forecasts to 2019" report to their offering. ... is estimated to grow at a lower CAGR in developed countries; ... such as China , India ... years. The growth of the hematology analyzers and reagents ...
Breaking Medicine Technology:DURECT Corporation Invites You to Join its Second Quarter 2014 Earnings Conference Call 2AMCP Endorses JCPP "Pharmacists' Patient Care Process" 2Hematology Analyzers & Reagents Market - Forecasts to 2019 2
... Watson Pharmaceuticals, Inc. (NYSE: WPI ... a portfolio of generic pharmaceutical products that are ... between Perrigo Company and Paddock Laboratories.  The portfolio ... and two undisclosed development-stage products.  Commercialized products in ...
... 26, 2011 Do you have questions about medical devices ... ventilators to blood pressure monitors. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... hosted by the Food and Drug Administration,s Center for Devices ... plans to address the increased use of medical devices in ...
Cached Medicine Technology:Watson Enters into Agreement to Acquire Products Related to Perrigo's Acquisition of Paddock Laboratories 2FDA Consumer Health Information - July 28 Webinar: Home Use of Medical Devices 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: